Study of ARO-DIMERPA in Adult Participants With Mixed Hyperlipidemia

Clinical trial NCT07223658 · RECRUITING

Trial details

NCT number: NCT07223658
Sponsor: Arrowhead Pharmaceuticals
Status: RECRUITING
Phase: Phase 1, Phase 2
Study type: INTERVENTIONAL

Hyperlipidemia; Mixed

Start date: 2025-12-22
Primary completion: 2026-09-30
Enrollment: 78

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.